study | mecfa

MECFA Blog

Study Finds Funding Disparities Between Sickle Cell Disease, Cystic Fibrosis

Disparities in funding exist between sickle cell disease (SCD) and cystic fibrosis (CF), according to a new study published in JAMA...

The surprising drugs that could help curb depression, according to new study -Some aren't convin

A new study has found that painkillers, statins and fish oils may help curb depression, especially if taken with antidepressants. The...

Viral Respiratory Tract Infections in Young CF Children Usually Mild, Study Found

Viral respiratory tract infections in young children with cystic fibrosis tend to be mild and not require hospitalization, a study found....

Gene Editing Tool Corrects CF-causing Mutations in Patient-derived Cells, Study Shows

Using the CRISPR gene editing tool, a team of researchers was able to permanently correct two mutations in the CFTR gene — mutations that...

Hyperbaric Oxygen Treatment May Make Antiobiotics More Effective Against P. aeruginosa Infections, S

Exposing cystic fibrosis (CF) patients to high levels of oxygen through hyperbaric oxygen treatment may make Pseudomonas aeruginosa...

Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies

AUSTIN, Texas, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today provided an update on...

Link Found Between P. aeruginosa Infection and Disease Severity in CF Patients, Study Reports

Patients with cystic fibrosis (CF) whose lungs have never been colonized by the Pseudomonas aeruginosa bacterium have a milder form of...

Omega-3 Essential Fatty Acids May Benefit Cystic Fibrosis Patients, Mouse Study Suggests

Dietary supplementation with a type of omega-3 essential fatty acid during pregnancy and in offspring for 60 days after birth improved...

Nanoparticles Therapy May Be ‘One-Size-Fits-All’ Approach for CF, Study Suggests

A potential therapy delivered through nanoparticles enables production of the normal, healthy form of the key CFTR protein in cystic...

#ECFS2018 — Hard-to-Treat Infections May Not Impact Survival of CF Patients After Lung Transplant, S

One-year survival after a lung transplant of cystic fibrosis (CF) patients chronically infected with antibiotic-resistant bacteria is...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p